FIELD: pharmaceutics. SUBSTANCE: solid dosage form for oral administration with controlled release of effective agent is prepared by covering particulate material containing active ingredient with water- repellent material having melting point of 50-90 C. EFFECT: high efficacy of dosage form.
| Title | Year | Author | Number |
|---|---|---|---|
| DELAYED-RELEASE ORAL DOSAGE FORM OF GABAPENTIN | 2005 |
|
RU2440112C2 |
| TAPENTADOL COMPOSITIONS FOR PAIN MANAGEMENT | 2008 |
|
RU2497512C2 |
| SOLID OR SEMI-LIQUID TIME-RELEASE DOSAGE FORMS | 2008 |
|
RU2471480C2 |
| SYNERGETIC ANALGETIC COMBINATION OF OPIOID ANALGETIC AGENT AND CYCLOOXYGENASE-2 INHIBITOR | 1998 |
|
RU2232600C2 |
| PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE RECEPTOR 5 (MGLU5) ANTAGONISTS | 2011 |
|
RU2602955C2 |
| CONTROLLED-RELEASE FORMULATION | 2006 |
|
RU2385712C2 |
| TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS | 2014 |
|
RU2674345C2 |
| STABLE PHARMACEUTICAL COMPOSITION CONTAINING WATER-SOLUBLE VINFLUNINE SALT | 2008 |
|
RU2462248C2 |
| ORAL DOSAGE FORMS OF TOFACITINIB WITH CONTINUOUS RELEASE | 2014 |
|
RU2790166C2 |
| CONTROLLED-RELEASE HYDROCODON COMPOSITION | 2001 |
|
RU2253452C2 |
